Table 4 Current clinical trials of Ivosidenib for leukemia patients
From: Advances in targeted therapy for acute myeloid leukemia
ClinicalTrials. gov Identifier | Phase | Enrollment Number | Disease Conditons | Status | Lead Institution/Location |
|---|---|---|---|---|---|
NCT04250051 | 1 | 25 | R/R AML R/R MDS R/R MPN | Not yet recruiting | Northwestern University, USA |
NCT03839771 | 3 | 968 | AML MDS EB-2 | Active, recruiting | Erasmus MC, Netherland |
NCT03173248 | 3 | 392 | Newly Diagnosed AML AML Arising From MDS | Active, recruiting | City of Hope, USA |
NCT02677922 | 1,2 | 131 | AML | Active, not recruiting | City of Hope, USA |
NCT04176393 | 1 | 30 | R/R AML | Active, recruiting | Institute of Hematology and Blood Diseases Hospital, CAMS, China |
NCT02632708 | 1 | 153 | Newly Diagnosed AML AML Arising From MDS, AHD AML Arising After Exposure to Genotoxic Injury | Active, not recruiting | City of Hope, USA |
NCT04044209 | 2 | 45 | MDS AML | Active, not recruiting | Yale Cancer Center, USA |
NCT03471260 | 1,2 | 48 | High risk MDS MPN R/R AML | Active, recruiting | Northwestern Medicine Cancer Center Delnor, USA |
NCT03503409 | 2 | 68 | MDS AML | Active, recruiting | CH Angers, France |
NCT02074839 | 1 | 291 | R/R AML Other IDH1 mutated+ Hematologic Malignancies MDS | Active, recruiting | Birmingham, USA |